Rheumatology

Editorial. Changing times
pp. 1-2(2)
Author: Scott, DL

Disease-modifying drug series#Glucocorticosteroids in the management of rheumatoid arthritis
pp. 6-12(7)
Authors: Laan, RFJM; Jansen, TLTA; Van Riel, PLCM

Review. Bibliometric methods for the evaluation of arthritis research
pp. 13-20(8)
Authors: Lewison, G; Devey, ME

Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis
pp. 21-27(7)
Authors: Toussirot, E; Ricard-Blum, S; Dumoulin, G; Cedoz, JP; Wendling, D

Glomerular and tubular proteinuria as markers of nephropathy in rheumatoid arthritis
pp. 28-33(6)
Authors: Niederstadt, C; Happ, T; Tatsis, E; Schnabel, A; Steinhoff, J

Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis
pp. 34-42(9)
Authors: Hummel, K.; Gay, R.; Gay, S.; Bresnihan, B.; Cunnane, G.; FitzGerald, O.

The therapeutic response to D-penicillamine in rheumatoid arthritis: influence of glutathione S-transferase polymorphisms
pp. 43-47(5)
Authors: Jones, P.; Alldersea, J.; Strange, R.; Fryer, A.; Mattey, D.; Layton, M.; Dawes, P.

A patient-derived disease activity score can substitute for a physician-derived disease activity score in clinical research
pp. 48-52(5)
Authors: Houssien, DA; Stucki, G; Scott, DL

the influence of a partially HLA-matched blood transfusion on the disease activity of rheumatoid arthritis
pp. 53-58(6)
Authors: van der Horst-Bruinsma, IE; Huizinga, TWJ; Lagaay, EM; Hazes, JMW; Breedveld, FC; Schreuder, GMT; Tomson, TAS; Zwinderman, AH; van Rood, JJ; de Vries, RRP

Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus
pp. 59-65(7)
Authors: Kipen, Y; Briganti, EM; Strauss, BJG; Littlejohn, GO; Morand, EF

Finger joint synovitis in rheumatoid arthritis: quantitative assessment by magnetic resonance imaging
pp. 66-72(7)
Authors: Klarlund, M; Østergaard, M; Lorenzen, I

Report. Knee replacement surgery for osteoarthritis: effectiveness, practice variations, indications and possible determinants of utilization
pp. 73-83(11)
Authors: Dieppe, P; Basler, H-D; Chard, J; Croft, P; Dixon, J; Hurley, M; Lohmander, S; Raspe, H

Letter. Catastrophic antiphospholipid syndrome associated with anti-beta-2-glycoprotein I IgA
pp. 84-85(2)
Authors: Abinader, A; Hanly, AJ; Lozada, CJ